LONDON, Nov 4 (Reuters) - Regulators might approve different
coronavirus vaccines candidates at different times but that is
not a problem, the chief trial investigator for the shot
developed at Oxford University said on Wednesday.
"I would not imagine that either developers can submit for
approval in all regulatory authorities at the same time, or that
all regulatory authorities will take the same time for
approval," Oxford's Andrew Pollard told lawmakers.
"I think it is likely that we will have some regulatory
approvals happening before others. And I don't see that as a
problem."
(Reporting by Alistair Smout, Editing by Paul Sandle)